# SMART-SF Radiofrequency Ablation Safety Study

> **NCT02359890** · PHASE3 · COMPLETED · sponsor: **Biosense Webster, Inc.** · enrollment: 165 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** THERMOCOOL® SMARTTOUCH® (RF ablation treatment)

## Key facts

- **NCT ID:** NCT02359890
- **Lead sponsor:** Biosense Webster, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-01
- **Primary completion:** 2015-09-01
- **Final completion:** 2016-11-08
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02359890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02359890, "SMART-SF Radiofrequency Ablation Safety Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02359890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*